in

Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie to Develop Next-Generation Therapies for Glaucoma Management

Source link : https://news7.asia/news/ripple-therapeutics-announces-collaboration-and-option-to-license-agreement-with-abbvie-to-develop-next-generation-therapies-for-glaucoma-management/

TORONTO, ON, Sep 17, 2024 – (ACN Newswire) – Ripple Therapeutics today announced a collaboration and option-to-license agreement with AbbVie to develop RTC-620, a next generation, fully biodegradable, sustained release drug delivery intracameral implant with repeat dosing capabilities to reduce intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT…
Source : ACN Newswire

Author : News7

Publish date : 2024-09-19 01:45:18

Copyright for syndicated content belongs to the linked Source.

Indiana basketball guard Jakai Newton ‘hasn’t fully recovered’ from knee injury

Salt Lake City International Airport, United States (Code :: SLC)